UPDATE - Barclays Initiates Coverage on Health Care REIT (HCN) with an Overweight; It's a Family Affair
Get Alerts HCN Hot Sheet
Price: $52.22 -4.01%
Rating Summary:
5 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
5 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Barclays initiates coverage on Health Care REIT (NYSE: HCN) with an Overweight. PT $55.00.
Barclays analyst said, "Given the uncertain economy and reimbursement environment, we believe that the defensive nature of Health Care REITs overall and the stability of the company's tenants will provide a solid base for the company's net operating income (NOI). Additionally, we believe that the company's investment in operating assets in the senior living space is at the right time of the economic cycle and that the lease-up nature of these facilities provides HCN with the opportunity to show outsized growth in NOI."
To see more ratings changes on HCN, Click Here
Barclays analyst said, "Given the uncertain economy and reimbursement environment, we believe that the defensive nature of Health Care REITs overall and the stability of the company's tenants will provide a solid base for the company's net operating income (NOI). Additionally, we believe that the company's investment in operating assets in the senior living space is at the right time of the economic cycle and that the lease-up nature of these facilities provides HCN with the opportunity to show outsized growth in NOI."
To see more ratings changes on HCN, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Keefe, Bruyette & Woods Resumes Bank of Nova Scotia (BNS:CN) (BNS) at Outperform
- DA Davidson Starts Comfort Systems USA (FIX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share